Kalke, K.; Lehtinen, J.; Gnjatovic, J.; Lund, L.M.; Nyman, M.C.; Paavilainen, H.; Orpana, J.; Lasanen, T.; Frejborg, F.; Levanova, A.A.;
et al. Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity. Viruses 2020, 12, 1434.
https://doi.org/10.3390/v12121434
AMA Style
Kalke K, Lehtinen J, Gnjatovic J, Lund LM, Nyman MC, Paavilainen H, Orpana J, Lasanen T, Frejborg F, Levanova AA,
et al. Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity. Viruses. 2020; 12(12):1434.
https://doi.org/10.3390/v12121434
Chicago/Turabian Style
Kalke, Kiira, Jenni Lehtinen, Jelena Gnjatovic, Liisa M. Lund, Marie C. Nyman, Henrik Paavilainen, Julius Orpana, Tuomas Lasanen, Fanny Frejborg, Alesia A. Levanova,
and et al. 2020. "Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity" Viruses 12, no. 12: 1434.
https://doi.org/10.3390/v12121434
APA Style
Kalke, K., Lehtinen, J., Gnjatovic, J., Lund, L. M., Nyman, M. C., Paavilainen, H., Orpana, J., Lasanen, T., Frejborg, F., Levanova, A. A., Vuorinen, T., Poranen, M. M., & Hukkanen, V.
(2020). Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity. Viruses, 12(12), 1434.
https://doi.org/10.3390/v12121434